BioCentury
ARTICLE | Company News

Management tracks

December 14, 2016 12:02 AM UTC

Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) hired Graeme Bell as CFO, replacing Sapna Srivastava. Bell was CFO at Anacor Pharmaceuticals Inc., which Pfizer Inc. (NYSE:PFE) acquired. Srivastava will remain as a senior advisor...